The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema

Goggel R., Uhlig S.

Source: Eur Respir J 2005; 25: 849-857
Journal Issue: May
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Goggel R., Uhlig S.. The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. Eur Respir J 2005; 25: 849-857

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction
Source: Eur Respir J 2010; 36: 1165-1173
Year: 2010



Group V phospholipase A2 (gVPLA2) -induced eosinophil synthesis of LTC4 is independent of mitogen-activated protein kinases (MAPK) activation
Source: Eur Respir J 2001; 18: Suppl. 33, 408s
Year: 2001

Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002



Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


LSC - 2017 - Profibrotic signaling by TGF-ß involves NADPH oxidase 4 dependent activation of tyrosine kinase Src and mitochondrial ROS
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017

Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids
Source: Eur Respir J 2011; 37: 933-942
Year: 2011



Differential actions of phosphatidyinositol 3-kinase inhibitors on respiratory burst and leukotriene C4 generation in PAF-stimulated human eosinophils
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003

Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia: role of p38 MAP kinase
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001

Phosphoinositide 3-kinase ? inhibitor suppresses interleukin-17 expression in a murine asthma model
Source: Eur Respir J 2010; 36: 1448-1459
Year: 2010



A novel mechanism for upregulation of β2-integrin and adhesion of eosinophils by secretory group V phospholipase A2 independent of cytosolic phospholipase A2 activation
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Regulation and overexpression of 85-kDa cytosolic phospholipase A2 in asthma
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010


Mitogen activated protein kinase activated protein kinase 2 regulates actin stress fiber formation in ventilator associated lung injury
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008

Ventilation-induced activation of the mitogen-activated protein kinase pathway
Source: Eur Respir J 2002; 20: 946-956
Year: 2002



Extracellular signal-regulated kinase mediates na,k-atpase endocytosis and prevents alveolar fluid reabsorption after a single recruitment maneuver
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009

Effect of fudosteine on mucin production
Source: Eur Respir J 2008; 32: 1195-1202
Year: 2008



Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries
Source: Eur Respir J 2013; 41: 85-95
Year: 2013



Hemaglutinin (HA) of H5N1 disturbs cAMP-dependent CFTR channel via activation of janus kinase 3
Source: Annual Congress 2009 - Translational models of lung disease
Year: 2009


New drugs for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 233-246
Year: 2012